Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


The need for standardization of reporting in prostate MRI

MRI has become an established tool in the diagnosis, management and treatment of localized prostate cancer. However, standardized guidelines on reporting prostate MRI have not yet been developed. A recent consensus study proposes a certification framework for reporting prostate MRI in the UK.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Weinreb, J. et al. ACR stakeholder prostate summit. J. Am. Coll. Radiol. 17, 1068–1070 (2020).

    Article  Google Scholar 

  2. 2.

    Bloom, J. B. et al. “Super-active surveillance”: MRI ultrasound fusion biopsy and ablation for less invasive management of prostate cancer. Gland. Surg. 7, 166–187 (2018).

    Article  Google Scholar 

  3. 3.

    Weinreb, J. C. et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, version 2. Eur. Urol. 69, 16–40 (2016).

    Article  Google Scholar 

  4. 4.

    Turkbey, B. et al. Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2. Eur. Urol. 76, 340–351 (2019).

    Article  Google Scholar 

  5. 5.

    Barrett, T. et al. Certification in reporting multiparametric magnetic resonance imaging of the prostate: recommendations of a UK consensus meeting. BJU Int. (2020).

    Article  PubMed  Google Scholar 

  6. 6.

    Ahdoot, M. et al. MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N. Engl. J. Med. 382, 917–928 (2020).

    Article  Google Scholar 

  7. 7.

    Kasivisvanathan, V. et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N. Engl. J. Med. 378, 1767–1777 (2018).

    Article  Google Scholar 

  8. 8.

    Westphalen, A. C. et al. Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 296, 76–84 (2020).

    Article  Google Scholar 

  9. 9.

    Turkbey, B. & Oto, A. Factors impacting performance and reproducibility of PI-RADS. Can. Assoc. Radiol. J. (2020).

    Article  PubMed  Google Scholar 

Download references


The opinions expressed are those of the authors alone and do not necessarily represent those of the United States Government nor the National Institutes of Health (NIH). NIH does not endorse commercial products.

Author information



Corresponding author

Correspondence to Bradford J. Wood.

Ethics declarations

Competing interests

B.J.W. and B.T. receive royalties from NIH (indirectly from Philips) for intellectual property license agreements between NIH and Philips on related technologies. NIH has patents and intellectual property in the field, with B.J.W. and B.T. as inventors. NIH has cooperative research and development agreements with Philips, Siemens, Canon Medical, Boston Scientific, Celsion Corp, Xact Robotics, NVIDIA and research agreements with Angiodynamics, ArciTrax and Exact Imaging.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Turkbey, B., Wood, B.J. The need for standardization of reporting in prostate MRI. Nat Rev Urol 18, 195–196 (2021).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing